METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT

Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHRYER BRENDA, MURPHY PATRICIA D, RABIN MARK B, YOSHIKAWA MATTHEW, OLSON SHERI J, PARK MICHAEL, ESKANDARI TARA, JACKSON GEOFFREY M, WHITE MARGA B
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHRYER BRENDA
MURPHY PATRICIA D
RABIN MARK B
YOSHIKAWA MATTHEW
OLSON SHERI J
PARK MICHAEL
ESKANDARI TARA
JACKSON GEOFFREY M
WHITE MARGA B
description Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2014302494A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2014302494A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2014302494A93</originalsourceid><addsrcrecordid>eNrjZDD2dQ3x8HdR8HdTcPRz9ImM8vRzV3BUcApydjRScHf1c1Xw9APyPUJ9Hf0UgkOdvFydQ3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYmxgZGJpYmjpTFxqgDfdCdG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><source>esp@cenet</source><creator>SCHRYER BRENDA ; MURPHY PATRICIA D ; RABIN MARK B ; YOSHIKAWA MATTHEW ; OLSON SHERI J ; PARK MICHAEL ; ESKANDARI TARA ; JACKSON GEOFFREY M ; WHITE MARGA B</creator><creatorcontrib>SCHRYER BRENDA ; MURPHY PATRICIA D ; RABIN MARK B ; YOSHIKAWA MATTHEW ; OLSON SHERI J ; PARK MICHAEL ; ESKANDARI TARA ; JACKSON GEOFFREY M ; WHITE MARGA B</creatorcontrib><description>Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141009&amp;DB=EPODOC&amp;CC=US&amp;NR=2014302494A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141009&amp;DB=EPODOC&amp;CC=US&amp;NR=2014302494A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHRYER BRENDA</creatorcontrib><creatorcontrib>MURPHY PATRICIA D</creatorcontrib><creatorcontrib>RABIN MARK B</creatorcontrib><creatorcontrib>YOSHIKAWA MATTHEW</creatorcontrib><creatorcontrib>OLSON SHERI J</creatorcontrib><creatorcontrib>PARK MICHAEL</creatorcontrib><creatorcontrib>ESKANDARI TARA</creatorcontrib><creatorcontrib>JACKSON GEOFFREY M</creatorcontrib><creatorcontrib>WHITE MARGA B</creatorcontrib><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><description>Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD2dQ3x8HdR8HdTcPRz9ImM8vRzV3BUcApydjRScHf1c1Xw9APyPUJ9Hf0UgkOdvFydQ3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYmxgZGJpYmjpTFxqgDfdCdG</recordid><startdate>20141009</startdate><enddate>20141009</enddate><creator>SCHRYER BRENDA</creator><creator>MURPHY PATRICIA D</creator><creator>RABIN MARK B</creator><creator>YOSHIKAWA MATTHEW</creator><creator>OLSON SHERI J</creator><creator>PARK MICHAEL</creator><creator>ESKANDARI TARA</creator><creator>JACKSON GEOFFREY M</creator><creator>WHITE MARGA B</creator><scope>EVB</scope></search><sort><creationdate>20141009</creationdate><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><author>SCHRYER BRENDA ; MURPHY PATRICIA D ; RABIN MARK B ; YOSHIKAWA MATTHEW ; OLSON SHERI J ; PARK MICHAEL ; ESKANDARI TARA ; JACKSON GEOFFREY M ; WHITE MARGA B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2014302494A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHRYER BRENDA</creatorcontrib><creatorcontrib>MURPHY PATRICIA D</creatorcontrib><creatorcontrib>RABIN MARK B</creatorcontrib><creatorcontrib>YOSHIKAWA MATTHEW</creatorcontrib><creatorcontrib>OLSON SHERI J</creatorcontrib><creatorcontrib>PARK MICHAEL</creatorcontrib><creatorcontrib>ESKANDARI TARA</creatorcontrib><creatorcontrib>JACKSON GEOFFREY M</creatorcontrib><creatorcontrib>WHITE MARGA B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHRYER BRENDA</au><au>MURPHY PATRICIA D</au><au>RABIN MARK B</au><au>YOSHIKAWA MATTHEW</au><au>OLSON SHERI J</au><au>PARK MICHAEL</au><au>ESKANDARI TARA</au><au>JACKSON GEOFFREY M</au><au>WHITE MARGA B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><date>2014-10-09</date><risdate>2014</risdate><abstract>Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2014302494A9
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
title METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A01%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHRYER%20BRENDA&rft.date=2014-10-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2014302494A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true